Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 22:50:13 - browse：67329

Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Menendez indictment could see pharma lose a key ally

explore

WSS

Menendez indictment could see pharma lose a key ally

CDC's new outbreak response network to include Northeastern

CDC advisers recommend seasonal use of Pfizer RSV shot

After a drawn out lobbying fight, ARPA

Lasker Awards 2023: Winners in biomedical research

FDA seeks to regulate lab

focus

Wikipedia

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Medical leaders decry Supreme Court decision on affirmative action

Senate HELP committee spars over health care workforce policies

Affirmative action in medical school literally saved lives

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Moonlake's readout produced a cash windfall. Risks remain

Ukraine and a new approach to mental health in war

Walensky prepares to leave CDC — and Congress — behind

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

focus

EpiPen alternative approval delay highlights citizen petition issue

FDA advisers vote against ALS treatment from BrainStorm

Paxlovid should be available without a positive Covid test

Why do women spend more than men on medical expenses?

Second xenotransplant done with gene

Lasker Awards 2023: Winners in biomedical research

explore

entertainment

explore

hotspot